🎉 M&A multiples are live!
Check it out!

Ourofino Valuation Multiples

Discover revenue and EBITDA valuation multiples for Ourofino and similar public comparables like Galapagos, Vivoryon Therapeutics, and Julphar.

Ourofino Overview

About Ourofino

Ourofino SA is engaged in research, development, production and sales of medicines, vaccines and other veterinary products. The company's reportable segments are Production animals, Companion animals, and International operations. It generates maximum revenue from the Production animals segment. The product portfolio includes Anticoccidials, Antimastitics, Biological, Ectoparasiticides, Endectocides, and others.


Founded

2014

HQ

Brazil
Employees

1.1K+

Website

ourofino.com

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

$229M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Ourofino Financials

Ourofino has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Ourofino achieved revenue of $179M and an EBITDA of $42.9M.

Ourofino expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Ourofino valuation multiples based on analyst estimates

Ourofino P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $164M $179M XXX XXX XXX
Gross Profit $92.1M $75.3M XXX XXX XXX
Gross Margin 56% 42% XXX XXX XXX
EBITDA $22.3M $42.9M XXX XXX XXX
EBITDA Margin 14% 24% XXX XXX XXX
Net Profit $22.8M -$8.7M XXX XXX XXX
Net Margin 14% -5% XXX XXX XXX
Net Debt $43.1M $22.3M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Ourofino Stock Performance

As of April 15, 2025, Ourofino's stock price is BRL 22 (or $4).

Ourofino has current market cap of BRL 1.2B (or $204M), and EV of BRL 1.3B (or $229M).

See Ourofino trading valuation data

Ourofino Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$229M $204M XXX XXX XXX XXX n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Ourofino Valuation Multiples

As of April 15, 2025, Ourofino has market cap of $204M and EV of $229M.

Ourofino's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Ourofino's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Ourofino and 10K+ public comps

Ourofino Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $229M XXX XXX XXX
EV/Revenue 1.3x XXX XXX XXX
EV/EBITDA 5.3x XXX XXX XXX
P/E 8.7x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF 44.9x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Ourofino Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Ourofino Valuation Multiples

Ourofino's NTM/LTM revenue growth is n/a

Ourofino's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Over next 12 months, Ourofino's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Ourofino's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Ourofino and other 10K+ public comps

Ourofino Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 9% XXX XXX XXX XXX
EBITDA Margin 24% XXX XXX XXX XXX
EBITDA Growth 92% XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee $0.2M XXX XXX XXX XXX
Opex per Employee $0.1M XXX XXX XXX XXX
S&M Expenses to Revenue 6% XXX XXX XXX XXX
G&A Expenses to Revenue 2% XXX XXX XXX XXX
R&D Expenses to Revenue 5% XXX XXX XXX XXX
Opex to Revenue 32% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Ourofino Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics and Vaccines & Immunotherapies comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Ourofino M&A and Investment Activity

Ourofino acquired  XXX companies to date.

Last acquisition by Ourofino was  XXXXXXXX, XXXXX XXXXX XXXXXX . Ourofino acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Ourofino

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Ourofino

When was Ourofino founded? Ourofino was founded in 2014.
Where is Ourofino headquartered? Ourofino is headquartered in Brazil.
How many employees does Ourofino have? As of today, Ourofino has 1.1K+ employees.
Is Ourofino publicy listed? Yes, Ourofino is a public company listed on BVMF.
What is the stock symbol of Ourofino? Ourofino trades under OFSA3 ticker.
When did Ourofino go public? Ourofino went public in 2014.
Who are competitors of Ourofino? Similar companies to Ourofino include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Ourofino? Ourofino's current market cap is $204M
What is the current revenue growth of Ourofino? Ourofino revenue growth between 2023 and 2024 was 9%.
Is Ourofino profitable? Yes, Ourofino is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.